Hansoh Pharmaceutical Group's high P/E ratio may be due to expected earnings recovery. However, with lower than market growth forecast, the high P/E ratio and positive investor sentiment may not be sustainable. Current trading prices may not be reasonable without significant improvement.
Hansoh Pharmaceutical Group's strong financials and moderate growth over the past five years, along with its high rate of profit reinvestment, could potentially boost its stock value in the long-term. Analysts anticipate future earnings momentum.
$恒生指数(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$荣昌生物(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $三叶草生物-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$维亚生物(01873.HK)$...
Despite Hansoh Pharmaceutical's high P/E ratio, its minimal earnings growth and slower future growth vs. the market make its valuation questionable. Shareholders and investors may face disappointment as the high P/E isn't justified by the growth outlook.
Hansoh Pharmaceutical's commendable ROE, impressive earnings growth, and profit reinvestment strategy signal positive performance. Future payout ratio is pegged around 22% and ROE about 12%. Analysts foresee gain in the company's earnings.
Hong Kong stocks advanced, halting a six-day decline as tech companies fueled the biggest market rally in two weeks. A government report showing slower inflation in China helped boost the outlook for more monetary easing to shore up the economy. $恒生指数(800000.HK)$climbed 2.6% at 19,342.98 at the local noon trading break, the most since August 25.$恒生科技指数(800700.HK)$su...
2
3
举报
Norton Symantec :
Hi, do you think HS index will up next week and hit 20k?
翰森制药股票讨论区
As for financials, $汇丰控股(00005.HK)$ opened flat at $57.95. $香港交易所(00388.HK)$ lost 0.5% at $231.4. $友邦保险(01299.HK)$ shed 1.6% at $58.65. Chinese prope...
HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off
Pharmaceuticals were sold off. $荣昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三叶草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $维亚生物(01873.HK)$ ...
HSI Closes at 17,406, Up 7 pts; HSTI Closes at 3,854, Up 48 pts; PSBC Down over 6%; XIAOMI, LENOVO GROUP Hit New Highs
Active Heavyweights:
$建设银行(00939.HK)$ closed at $4.48, down 1.8%
$腾讯控股(00700.HK)$ closed at $295.4, up 0.9%
$美团-W(03690.HK)$ closed at $...
Alibaba, Tencent, pharma stocks fuel best rally in two weeks as China inflation report boosts stimulus bets
$恒生指数(800000.HK)$ climbed 2.6% at 19,342.98 at the local noon trading break, the most since August 25. $恒生科技指数(800700.HK)$ su...
暂无评论